|
CV Information
 PROFESOR MADYA DR. AZLAN BIN HUSIN
| |
|---|---|
|
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
| |
| 1 | , "A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF COPANLISIB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED INDOLENT B-CELL NON-HODGKIN’S LYMPHOMA (INHL)- CHRONOS-3" (02.03.2017 - 01.03.2018) [ Bayer Health Care ] - Source: HCMSv3 |
| 2 | , "A PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY OF ALXN1210 VERSUS ECULIZUMAB IN COMPLEMENT INHIBITOR-NAïVE ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)" (05.12.2016 - 31.01.2023) [ Alexion Pharmaceuticals, Inc ] - Source: HCMSv3 |
| 3 | , "GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD OBSERVING TREATMENT AND OUTCOMES IN PATIENTS WITH TREATED ACUTE VENOUS THROMBOEMBOLIC EVENTS IN THE REAL WORLD" (30.11.2015 - 30.11.2016) (03) [ Thrombosis Research Institute, UK ] - Source: HCMSv3 |
| 4 | , "A MULTICENTER, RANDOMISED, OPEN-LABEL, THREE-PARALLEL GROUPS, PHASE 2-3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MASITINIB WITH DEXAMETHASONE, GEMCITABINE WITH DEXAMETHASONE AND THE COMBINATION OF MASITINIB, GEMCITABINE AND DEXAMETHASONE IN PATIE" (16.03.2015 - 28.02.2018) (03) [ AB Science ] - Source: HCMSv3 |
| 5 | , "A COMPARATIVE EVALUATION OF THE SAFETY AND EFFICACY OF DAPTOMYCIN VERSUS STANDARD OF CARE IN PEDIATRIC SUBJECTS TWO - SEVENTEEN YEARS OF AGE WITH BACTEREMIA CAUSED BY STAPHYLOCOCCUS AUREUS." (30.01.2015 - 31.12.2015) (03) [ Cubist Pharmaceutical Inc ] - Source: HCMSv3 |
| 6 | , "PAROXYSMAL NOCTURNAL HAEMAOGLOBINURIA (PNH) REGISTRY" (01.05.2014 - 30.04.2016) [ Alexion Pharmaceutical, Inc ] - Source: HCMSv3 |
| 7 | , "PAROXYSMAL NOCTURNAL HAEMOGLOBULINEMIA REGISRTY" (26.03.2014 - 26.03.2016) (03) [ Alexion Pharmaceutical Inc ] - Source: HCMSv3 |
